Effects of CAR-T Cell Therapy on Immune Cells and Related Toxic Side Effect Analysis in Patients with Refractory Acute Lymphoblastic Leukemia

Table 2

Comparison of Treg cell level before and after treatment ().

Groups	Treg cells (%)	NK cells (%)
Before treatment ()
CR+CRi patients treated for 1 month ()	^a	^a
CR+CRi patients treated for 3 months ()	^ab	^ab
PD patients treated for 1 month ()	^bc
	7.500	17.770
	<0.001	<0.001

^a compared with before treatment; ^b compared with CR+CRi patients treated for 1 month; ^c compared with CR+CRi patients treated for 3 months.